Literature DB >> 2403823

Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta.

J D Cashman1, A C Eaves, E W Raines, R Ross, C J Eaves.   

Abstract

Long-term marrow cultures (LTMC) allow the proliferation and differentiation of primitive human hematopoietic progenitor cells to be maintained for many weeks in the absence of exogenously provided hematopoietic growth factors. Previous investigations focused on defining various types of cells that are present in this culture system and on measuring the cycling behavior of the different subpopulations of colony-forming cells maintained within it. These studies suggested that mesenchymal stromal elements derived from the input marrow play a key role in regulating the turnover of the most primitive, high-proliferative potential erythroid and granulopoietic colony-forming cells that are found almost exclusively in the adherent layer of LTMC. In this study we show that the re-entry into S-phase of these primitive hematopoietic progenitors that occurs after each weekly medium change is due to an as yet undefined constituent of horse serum, which is absent from fetal calf serum. However, this effect is not unique to the factor present in horse serum. It is also elicited by the addition to LTMC of several well-defined growth regulatory molecules, ie, platelet-derived growth factor (PDGF), interleukin-1 (IL-1), transforming growth factor alpha (TGF-alpha), and IL-2. None of these was able to stimulate hematopoietic colony-forming cells in methylcellulose assays, although all have known actions on mesenchymal cells including, in some cases, the ability to increase production of growth factors that can stimulate primitive high-proliferative potential hematopoietic progenitors in clonogenic assays. Interestingly, a stimulating effect was not obtained after addition of endotoxin to LTMC. TGF-beta, a direct-acting negative regulator that acts selectively on primitive hematopoietic progenitor cells if added to LTMC simultaneously with new medium or IL-1, blocked their stimulating activity. These results suggest a model in which indirect, local modulation of both positive and negative regulatory factors via effects on mesenchymal elements determines the rate of turnover of adjacent populations of very primitive hematopoietic cells that are normally maintained in a quiescent state in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403823

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells.

Authors:  T Otsuka; J D Thacker; C J Eaves; D E Hogge
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  Establishment of an osteogenic cell line derived from adult mouse bone marrow stroma by use of a recombinant retrovirus.

Authors:  E Mathieu; G Schoeters; F vander Plaetse; J Merregaert
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

3.  Interferon-alpha restores normal adhesion of chronic myelogenous leukemia hematopoietic progenitors to bone marrow stroma by correcting impaired beta 1 integrin receptor function.

Authors:  R Bhatia; E A Wayner; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 4.  TGF-β signaling and its role in the regulation of hematopoietic stem cells.

Authors:  Anuradha Vaidya; Vaijayanti P Kale
Journal:  Syst Synth Biol       Date:  2015-01-29

5.  Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.

Authors:  Alice Giustacchini; Supat Thongjuea; Nikolaos Barkas; Petter S Woll; Benjamin J Povinelli; Christopher A G Booth; Paul Sopp; Ruggiero Norfo; Alba Rodriguez-Meira; Neil Ashley; Lauren Jamieson; Paresh Vyas; Kristina Anderson; Åsa Segerstolpe; Hong Qian; Ulla Olsson-Strömberg; Satu Mustjoki; Rickard Sandberg; Sten Eirik W Jacobsen; Adam J Mead
Journal:  Nat Med       Date:  2017-05-15       Impact factor: 53.440

6.  Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

Authors:  H J Sutherland; P M Lansdorp; D H Henkelman; A C Eaves; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors. Role of MIP-1 alpha.

Authors:  R Bhatia; P B McGlave; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

8.  Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation.

Authors:  R W Hurley; J B McCarthy; C M Verfaillie
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Cell-cell interaction networks regulate blood stem and progenitor cell fate.

Authors:  Daniel C Kirouac; Gerard J Madlambayan; Mei Yu; Edward A Sykes; Caryn Ito; Peter W Zandstra
Journal:  Mol Syst Biol       Date:  2009-07-28       Impact factor: 11.429

10.  Establishment and characterization of a new murine cell line (SR-4987) derived from marrow stromal cells.

Authors:  A Pessina; E Mineo; M G Neri; L Gribaldo; R Colombi; P Brambilla; G Zaleskis
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.